UI Pharmaceuticals (UIP), a division of the University of Iowa College of Pharmacy, has partnered with New York-based MimiVax to support the manufacturing of SurVaxM — a novel immunotherapeutic vaccine designed to treat glioblastoma, one of the most aggressive forms…